Download Files:
Products Details
Product Description
– HBV-IN-9 is a potent HBsAg (HBV Surface antigen) inhibitor (IC50=10 nM) and HBV DNA production inhibitor (IC50=0.15 nM in HepG2.2.15 cells)[1]. From patent WO2018001952A1, example 20.
Web ID
– HY-145052
Shipping
– Room temperature
Applications
– COVID-19-anti-virus
Molecular Formula
– C22H24FN7O
References
– [1]Zhanling CHENG, et al. Novel tetrahydropyridopyrimidines for the treatment and prophylaxis of hbv infection. WO2018001952A1.
CAS Number
– 2170998-69-1
Molecular Weight
– 421.47
SMILES
– FC1=CC(N2CCC(C2)OC)=CC(N3CCC4=C(C3C)C=NC(C5=NC=CC=N5)=N4)=N1
Clinical Information
– No Development Reported
Research Area
– Infection
Solubility
– 10 mM in DMSO
Target
– HBV
Pathway
– Anti-infection
Product type
– Reference compound
Disclaimer: All products are for Research use only unless clearly stated otherwise on the product datasheet. Datasheets provided on the website are drafts for reference purpose only and you are requested to always refer to the hard copy included in the kit for your experimentation. Agdia Products are available for delivery only in Canada.
